help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valyasevi, R. W.
Right arrow Articles by Bahn, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valyasevi, R. W.
Right arrow Articles by Bahn, R. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 7 2557-2562
Copyright © 1999 by The Endocrine Society

Original Studies

Differentiation of Human Orbital Preadipocyte Fibroblasts Induces Expression of Functional Thyrotropin Receptor1

Rosanee W. Valyasevi, Dana Z. Erickson, Debra A. Harteneck, Charyl M. Dutton, Armin E. Heufelder, Soma C. Jyonouchi and Rebecca S. Bahn

Division of Endocrinology, Mayo Clinic/Foundation (R.W.V., D.Z.E., D.A.H., C.M.D., S.C.J., R.S.B.), Rochester, Minnesota 55905; and Medizinische Klinik, Klinikum Innenstadt, University of Munich (A.E.H.), 80336 Munich, Germany

Address all correspondence and requests for reprints to: Rebecca S. Bahn, M.D., Division of Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. E-mail: bahn.rebecca{at}mayo.edu

Although the autoantigen involved in Graves’ hyperthyroidism is known to be the TSH receptor (TSHr), whether this antigen plays a primary role in the pathogenesis of Graves’ ophthalmopathy (GO) is unclear. We sought to determine whether fibroblasts derived from orbital adipose/connective tissue are capable of differentiating into adipocytes that bear immunoreactive and functional TSHr. In addition, we assessed relative levels of TSHr gene expression in normal and GO orbital adipose/connective tissue specimens.

GO and normal orbital preadipocyte fibroblasts, cultured under conditions known to stimulate adipocyte differentiation, showed evidence of adipogenesis and positive immunostaining for TSHr protein. In addition, significantly more cAMP was produced in response to TSH stimulation in the differentiated cultures than in undifferentiated cultures derived from the same individuals’ cells. Other studies demonstrated relatively greater TSHr gene expression in GO than in normal orbital tissue specimens.

These results indicate that orbital preadipocyte fibroblasts increase their TSHr expression with differentiation and suggest that these cells play an important role in the pathogenesis of GO. Furthermore, our studies support the concept that TSHr may be an important target antigen in this condition. Factors that stimulate adipocyte differentiation and TSHr expression in the orbit in GO have yet to be defined.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Tsui, V. Naik, N. Hoa, C. J. Hwang, N. F. Afifiyan, A. Sinha Hikim, A. G. Gianoukakis, R. S. Douglas, and T. J. Smith
Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease
J. Immunol., September 15, 2008; 181(6): 4397 - 4405.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Lu and R.-Y. Lin
TSH stimulates adipogenesis in mouse embryonic stem cells
J. Endocrinol., January 1, 2008; 196(1): 159 - 169.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. J. Cawood, P. Moriarty, C. O'Farrelly, and D. O'Shea
Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 59 - 64.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. Zhang, G. Baker, D. Janus, C. A. Paddon, D. Fuhrer, and M. Ludgate
Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5197 - 5203.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
T J Cawood, P Moriarty, C O'Farrelly, and D O'Shea
The effects of tumour necrosis factor-{alpha} and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis
Eur. J. Endocrinol., September 1, 2006; 155(3): 395 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Endocr. Rev., August 1, 2006; 27(5): 449 - 467.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. E. Feldon, D. J. J. Park, C. W. O'Loughlin, V. T. Nguyen, S. Landskroner-Eiger, D. Chang, T. H. Thatcher, and R. P. Phipps
Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves' Ophthalmopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3913 - 3921.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. M. McLachlan, Y. Nagayama, and B. Rapoport
Insight into Graves' Hyperthyroidism from Animal Models
Endocr. Rev., October 1, 2005; 26(6): 800 - 832.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kumar, A. Leontovich, M. J. Coenen, and R. S. Bahn
Gene Expression Profiling of Orbital Adipose Tissue from Patients with Graves' Ophthalmopathy: A Potential Role for Secreted Frizzled-Related Protein-1 in Orbital Adipogenesis
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4730 - 4735.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A Boschi, C. Daumerie, M Spiritus, C Beguin, M Senou, D Yuksel, M Duplicy, S Costagliola, M Ludgate, and M C Many
Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy
Br. J. Ophthalmol., June 1, 2005; 89(6): 724 - 729.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Agretti, G. De Marco, M. De Servi, C. Marcocci, P. Vitti, A. Pinchera, and M. Tonacchera
Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation
Eur. J. Endocrinol., May 1, 2005; 152(5): 777 - 784.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Baker, G. Mazziotti, C. von Ruhland, and M. Ludgate
Reevaluating Thyrotropin Receptor-Induced Mouse Models of Graves' Disease and Ophthalmopathy
Endocrinology, February 1, 2005; 146(2): 835 - 844.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kumar, M. J. Coenen, P. E. Scherer, and R. S. Bahn
Evidence for Enhanced Adipogenesis in the Orbits of Patients with Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 930 - 935.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. S. Prabhakar, R. S. Bahn, and T. J. Smith
Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy
Endocr. Rev., December 1, 2003; 24(6): 802 - 835.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Bahn
Pathophysiology of Graves' Ophthalmopathy: The Cycle of Disease
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1939 - 1946.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. Bell, A. Gagnon, P. Dods, D. Papineau, M. Tiberi, and A. Sorisky
TSH signaling and cell survival in 3T3-L1 preadipocytes
Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1056 - C1064.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. W. Valyasevi, D. A. Harteneck, C. M. Dutton, and R. S. Bahn
Stimulation of Adipogenesis, Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}), and Thyrotropin Receptor by PPAR{gamma} Agonist in Human Orbital Preadipocyte Fibroblasts
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2352 - 2358.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. Kazim, R. A. Goldberg, and T. J. Smith
Insights Into the Pathogenesis of Thyroid-Associated Orbitopathy: Evolving Rationale for Therapy
Arch Ophthalmol, March 1, 2002; 120(3): 380 - 386.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. J. Smith, L. Koumas, A. Gagnon, A. Bell, G. D. Sempowski, R. P. Phipps, and A. Sorisky
Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 385 - 392.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. W. Valyasevi, S. C. Jyonouchi, C. M. Dutton, N. Munsakul, and R. S. Bahn
Effect of Tumor Necrosis Factor-{{alpha}}, Interferon-{{gamma}}, and Transforming Growth Factor-{beta} on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 903 - 908.
[Abstract] [Full Text]

Home page
 IOVSHome page
M. Crisp, K. J. Starkey, C. Lane, J. Ham, and M. Ludgate
Adipogenesis in Thyroid Eye Disease
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3249 - 3255.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
L. Bartalena, A. Pinchera, and C. Marcocci
Management of Graves' Ophthalmopathy: Reality and Perspectives
Endocr. Rev., April 1, 2000; 21(2): 168 - 199.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society